The relationship between total bilirubin binding capacity (TBBC) and clinical status was investigated in order to assess the risk of bilirubin toxicity in 83 infants with jaundice in this study. Infants with respiratory distress, acidosis, hypoglycaemia, sepsis, asphyxia-anoxia and hypercarbia were accepted as ill and the remainders were well. Sephadex G-25 gel filtration method was used to determine TBBC. Serum albumin levels, TBBC and TBBC/albumin molar ratios were lower in ill premature and mature infants. Acidosis was the major risk factor for bilirubin toxicity in ill infants. Therefore, clinical status should be taken into consideration in the management of jaundiced infants.
Introduction
The risk for bilirubin encephalopathy in jaundiced infants is dependent on the serum concentration of unconjugated bilirubin and the ability of serum albumin to bind to bilirubin. It has been widely accepted that bilirubin toxicity occurs when free bilirubin enters the brain and binds to cell membranes. 1 If the molar concentration of bilirubin in the plasma is more than that of albumin, free bilirubin can be detected. 12 Several studies have suggested that clinical condition of the infant may alter the binding of bilirubin to albumin, and TBBC has been found to be lower in sick newborn infants. 34 The risk of bilirubin toxicity is reported to be higher among the babies with respiratory distress, acidosis, hypoglycaemia, neonatal sepsis, asphyxia-anoxia or hypercarbia.*•' Anoxia, hypercarbia, and hyperosmolality open the blood brain barrier and increase the deposition of bilirubin in the brain. 6 ' 7 Metabolic disturbances may alter albumin-bilirubin binding which may lead to bilirubin toxicity. 8 The aim of this study is to investigate the relationship between TBBC and clinical status of newborn infants.
Methods
A total of 83 jaundiced newborn infants (40 premature and 43 mature) admitted to the Neonatology Department of (^ukurova University Hospital were included in this study.
Gestational ages of the patients were calculated from the last normal menstrual period of the mothers or by using Farr's method. Reference 9 was used as a guide for normal limits according to gestational and postnatal age for each patient.
Sixty infants who did not have any of the risk factors listed above were considered well, and include 26 premature (gestation of 37 weeks or less) and 34 term infants.
Total and direct bilirubin concentrations and serum albumin levels were determined by using Technicon RA-XT (England). Sephadex G-25 gel filtration method, which was modified by Blondheim el al., li was used to determine TBBC of the patients.
The collected data were evaluated using SPSS-x. The statistical analyses were made by the Student ttest.
Results
The mean birth weights, gestational and postnatal ages of clinically ill and well infants are shown in Table  1 . There was no significant difference between birth weights of clinically ill and well premature or mature babies (P> 0.05). Gestational ages, and postnatal ages of ill and well babies were not different either in premature or mature groups (f>0.05).
Clinical abnormalities observed in 23 ill newborn infants are given in Table 2 . Acidosis was the most frequent problem in these infants (78 per cent). Hypoglycaemia, hypercarbia, respiratory distress, sepsis, and asphyxia-anoxia were found in decreasing frequencies. Serum albumin levels were significantly lower in clinically ill premature (P<0.05) and mature (/>< 0.01) infants (Table 3) .
Clinically ill premature and mature infants seemed to have lower TBBC than well premature and mature ones. The difference was significant for both premature {P<0.0\) and mature (P<0.001) groups (Table 3) .
TBBC/Albumin molar ratios were also lower in clinically ill infants than in the ones who were well. However, the difference was significant only in mature group (/><O.O5,Table3) Discussion Bilirubin is a poison that can produce transient encephalopathy or irreversible brain damage in newborn infants with unconjugated hyperbilirubinaemia.
Although there is an association of brain damage with high bilirubin levels, many babies with high serum concentrations of unconjugated bilirubin may escape brain damage, while others may develop bilirubin encephalopathy at relatively low serum levels. Bilirubin binding status, variations in blood brain barrier permeability, prenatal or postnatal asphyxia, and other metabolic insults play important role in this manner. 712 " 14 The risk of brain damage is reported to be closely associated with the clinical status of the infants. 13 Kim etal. 16 reported increased risk of kernicterus in infants with acidosis hypoxia, hypoalbuminaemia, and low TBBC. Cashore et al. 4 also reported low TBBC and low serum albumin levels in ill premature and mature infants. TBBC/Albumin molar ratio is found lower in mature ill infants in the same study. Hansen et al. reported increased deposition of bilirubin and albumin in brain during hypercarbia, 7 and Bratlid et al. found similar results during acidosis. 5 In our study serum albumin levels and TBBC were found to be lower in clinically ill infants in both premature and mature groups. TBBC/albumin molar ratios were also lower in ill infants than well ones, which is thought to be a risk factor for bilirubin toxicity.
Excess of hydrogen ion in severe acidosis has been implicated as a factor to displace the bilirubin from the albumin binding sites. 17 Diamond et a/. 18 reported that acidosis enhances the movement of bilirubin into the cell. Hypercarbia, which also produces acidosis, may cause opening of the blood-brain barrier to allow for entry of bilirubin into the brain. A total of 18 infants (78 per cent) were found to have acidosis in this study, and these infants were thought to be at high risk for bilirubin encephalopathy.
Since TBBC and TBBC/albumin molar ratios were quite low in ill infants and initiation of phototherapy or exchange transfusion would be necessary at lower serum total bilirubin levels, clinical condition of the baby should be taken into consideration in the management of jaundice.
